Compu Medical SE EBITDA
What is the EBITDA of Compu Medical SE?
The EBITDA of CompuGroup Medical SE is €159.741M
What is the definition of EBITDA?
EBITDA is a company’s earnings before interest, taxes, depreciation, and amortization and is an accounting measure calculated using a company’s net earnings, before interest expenses, taxes, depreciation and amortization are subtracted, as a proxy for a company’s current operating profitability.
ttm (trailing twelve months)
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA of companies in the Health Care sector on XETRA compared to Compu Medical SE
What does Compu Medical SE do?
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
Companies with ebitda similar to Compu Medical SE
- Park National has EBITDA of $159.142M
- Braemar Hotels & Resorts Inc has EBITDA of $159.189M
- Hypebeast has EBITDA of HKD$159.286M
- Treehouse Foods Inc has EBITDA of $159.600M
- Powell Industries has EBITDA of $159.641M
- Shenzhen Qingyi Photomask has EBITDA of ¥159.642M
- Compu Medical SE has EBITDA of €159.741M
- Man Yue Technology has EBITDA of HKD$159.820M
- ATRESMEDIA Corporacion de Medios de Comunicación SA has EBITDA of €159.869M
- Facor Alloys has EBITDA of ₨159.922M
- Dnow Inc has EBITDA of $160.000M
- Ceridian HCM has EBITDA of $160.000M
- The Go-Ahead Plc has EBITDA of £160.000M